Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income	$ 9,755,160	$ 2,216,562
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	210,665	(48,539)
Other-than-temporary impairments	393,455	(0)
Realized investment gains, net	(6,021,653)	(4,645,699)
Change in fair value of equity securities	(14,121,883)	(6,208,148)
Unrealized trading (gains) losses included in income	(2,059)	973
Realized trading (gains) losses included in income	(20,509)	(3,894)
Amortization of cost of insurance acquired	714,970	744,850
Depreciation and depletion	2,757,522	1,697,285
Stock-based compensation	287,934	325,668
Charges for mortality and administration of universal life and annuity products	(6,325,818)	(6,355,601)
Interest credited to account balances	3,896,162	4,012,179
Change in accrued investment income	77,484	338,140
Change in reinsurance receivables	88,449	541,295
Change in policy liabilities and accruals	(5,470,342)	(2,285,473)
Change in income taxes receivable (payable)	(1,243,870)	(45,165)
Change in other assets and liabilities, net	2,570,898	(3,527,819)
Net cash used in operating activities	(12,453,435)	(13,243,386)
Proceeds from investments sold and matured:
Fixed maturities available for sale	21,581,106	23,924,989
Equity securities	5,892,777	18,281,727
Trading securities	41,708	(579)
Mortgage loans	12,270,055	707,274
Real estate	8,370,848	11,983,353
Notes receivable	8,639,320	5,305,162
Policy loans	2,503,273	1,256,793
Short-term investments	0	18,500,000
Total proceeds from investments sold and matured	59,299,087	79,958,719
Cost of investments acquired:
Fixed maturities available for sale	(4,078,459)	(9,048,928)
Equity securities	(32,991,005)	(15,362,440)
Trading securities	(30,243)	15,719
Mortgage loans	(20,634,252)	(13,213,037)
Real estate	(10,960,910)	(2,995,519)
Notes receivable	(8,680,000)	(3,500,000)
Policy loans	(1,303,246)	(1,043,441)
Short-term investments	0	(7,890,228)
Total cost of investments acquired	(78,678,115)	(53,037,874)
Sale of property and equipment	1,324,647	0
Net cash provided by (used in) investing activities	(18,054,381)	26,920,845
Cash flows from financing activities:
Policyholder contract deposits	4,466,422	4,408,039
Policyholder contract withdrawals	(5,588,394)	(4,343,401)
Proceeds from notes payable/line of credit	24,000,000	0
Purchase of treasury stock	(537,379)	(3,313,154)
Issuance of stock	5,005	0
Non controlling contributions/(distributions) of consolidated subsidiary	(76,314)	(190,818)
Net cash provided by (used in) financing activities	22,269,340	(3,439,334)
Net increase (decrease) in cash and cash equivalents	(8,238,476)	10,238,125
Cash and cash equivalents at beginning of period	39,025,754	28,787,629
Cash and cash equivalents at end of period	$ 30,787,278	$ 39,025,754